by Heidi Stevenson
The now-traditional belief that Alzheimer’s disease is caused by a buildup of plaques on the brain has always been deficient for one simple reason: It completely ignores why those plaques build up. We now have good information that documents the reason for it. Alzheimer’s shares its genesis with diabetes. It’s a derangement of the body’s ability to process or produce insulin. Alzheimer’s is a third type of diabetes: type 3.
Alzheimer’s is a terrible disease that steals people’s twilight years, takes grandparents from children years before they actually die, and costs society untold resources. And this disastrous condition is a growing epidemic.
It should come as no surprise that Alzheimer’s is yet another chronic disease that can blamed on modern life. It’s long been known that it’s related to diet, that those who eat primarily from Agribusiness offerings are more likely to become afflicted. It may also be triggered by vaccinations.
The brain burns a great deal of energy. People who use their brains intensely, such as chess players, have a tendency to eat large amounts of sugary foods during matches. There’s a reason: It literally fuels their ability to think. That’s because glucose is a type of sugar, so eating it is a quick way to increase the brain’s energy.
There is, though, a big downside to bingeing on sugar. While it can temporarily give a boost to mental function, ultimately the ability to think can be destroyed.
Insulin is required to metabolize glucose. Sudden spurts of glucose in the blood stream normally result in increased production of insulin to move the excess glucose into cells, where it’s utilized. Cells can develop insulin resistance when glucose blood levels are too high, either fairly constantly or in surges. However, sugar must be cleared from the blood stream. Therefore, the pancreas will create more insulin in an attempt to get the excess sugar moved into cells.
That works for a time, but a vicious cycle is started. Too much glucose in the blood causes more insulin to be produced. More insulin causes cells to become resistant to it, which causes more insulin to be made, and that causes even more insulin resistance, which causes even more insulin to be made, which … You get the picture.
A study has shown that high glucose levels in the blood are associated with brain atrophy in Alzheimer’s patients2. Even when patients had not reached the point of being diabetic, high blood glucose was associated with brain atrophy.
Plaques are found in the brains of Alzheimer’s patients. It’s been commonly believed that these plaques are the cause of the disease. Now though, it’s clear that they are merely a symptom. The plaques are sticky deposits of a protein called ß-amyloid. They were believed to simply build up, for some unexplained reason, and destroy neurons (brain cells).
It now appears that they are the hardened form of a protein called amyloid ß-derived diffusible ligand—most commonly referred to as ADDL—which makes neurons resistant to insulin by removing insulin receptors3.
ADDL proteins are referred to as toxic1. However, they are made by the body and are found in normal brains. They exist for a reason. While the focus has been on the fact that they’re excessive in Alzheimer’s patients, the fact is that they do serve a purpose in normal brains. Just as high cholesterol is not a disease, but only a marker for some heart disease, we’d be going down the wrong path if we treated ADDL proteins as inherently harmful.
One can easily imagine that ADDL is necessary to stop glucose-saturated cells from taking up excess glucose, which can be harmful. If that’s the case, then trying to control ADDL artificially could—and probably would—be harmful. The suggestion that ADDL is the problem is short sighted. Of course, that’s exactly what we can expect of modern medicine and it’s collaborator, Big Pharma. In fact, one of the author of the paper that first reported on the plaques3, Grant A. Krafft, PhD, is on the board and is chief scientific officer for Acumen Pharmaceuticals, which was founded to take advantage of the ADDL-plaque discovery.
Northwestern University and USC jointly hold patents on the composition and use of ADDLs in neurodisorders. Acumen has licensed the rights the patent rights, which gives them the exclusive right to take advantage of drugs or other treatments that could control ADDLs.
As ever, the medical world’s focus is not on prevention, but on treatment. In the growing Alzheimer’s epidemic, the amount of money to be made on such treatments could be astronomical. Of course, this isn’t being done for the patients’ benefit. It’s being done for profits.
Obviously, diet is a factor in type 3 diabetes. Its similarity with type 2 diabetes, in which cells becomes insulin-resistant, is clear. However, as was documented in Vaccination Causes Diabetes, it’s likely that the trigger may often be vaccinations.
As has been documented at the Institute for Memory Impairments and Neurological Disorders at the University of California, Irvine, excess cortisol in the blood is a precursor and cause of Alzheimer’s disease6. As Vaccination Causes Diabetes notes, excess cortisol is also a cause of type 2 diabetes. The excessive inflammation and cortisol production caused by vaccinations can be identified as the trigger that often leads to diabetes.
That same vaccination-induced inflammatory process is a likely trigger of the vicious round of insulin resistance and increased insulin production. That cycle is the root of metabolic syndrome. Until we have solid research that demonstrates no such connection, it is only reasonable to assume that vaccinations trigger the metabolic syndrome that leads to type 3 diabetes-Alzheimer’s disease.
We will, of course, be informed that such a connection has never been documented. However, the same could be said of the connections between vaccinations and other conditions, such as autism, allergies, and diabetes. The proof of vaccination’s relationship to all these conditions could readily be found—but such studies aren’t being funded.
Such research would actually be quite simple. Compare a large group of unvaccinated people against an equivalent group of vaccinated people and see how many cases of these diseases and conditions exist in each group. A large unvaccinated group of people exists: the Amish of America do not vaccinate.5 As it happens, we have plenty of anecdotal evidence on the issue, and it speaks volumes. The fact is that there is hardly any diabetes, allergies, or autism among them. Those few who are afflicted with autism were adoptees, children who’d been vaccinated before joining the Amish.
Research is demonstrating that giving insulin to Alzheimer’s sufferers can ease, and perhaps even reverse, mental decline. It seems likely that Acumen Pharmaceuticals will find a drug – or two or three – that will attack the ADDL-induced plaque. However, as with any drug or treatment that addresses a symptom, rather than the underlying cause, any benefits will come at a cost.
Rather than focusing on treating Alzheimer’s patients, wouldn’t it be ever so much better to prevent it? Though the authors of the study showing that ADDL proteins are mostly interested in finding a drug to treat the disease, wouldn’t it be better to simply not lose your mind in the first place? We know how, so let’s just act on our knowledge.
No matter what your age or previous lifestyle, a good healthy diet, along with good exercise, can prevent Alzheimer’s or help alleviate it. Why waste your last years and put both emotional and financial stress on your family, when you could be living life to the hilt?
Enjoy every minute you have on this earth. Don’t hand your greatest wealth—your health and your mind—over to rampaging Agribusiness, Big Pharma, or Big Medicine.
Tagged agribusiness, alzheimer's diabetes, alzheimer's disease, alzheimer's is diabetes, big pharma, big pharma alzheimer's, big pharma type 3 diabetes, conventional medicine, diabetes, diabetes 3, diabetes type 3, diet alzheimer's, diet diabetes, pharmaceutical drugs, pharmaceuticals, science, vaccine, vaccines